Ocular tear growth factor-like protein

Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving antigen-antibody binding – specific binding protein...

Reexamination Certificate

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C435S007200, C435S069100, C435S070100, C530S350000, C436S501000

Reexamination Certificate

active

07320870

ABSTRACT:
The present invention relates to a novel lacrimal gland protein (designated lacritin) and the nucleic acid sequences encoding that protein. Lacritin has activity as a growth factor on both human corneal epithelial cells and on the lacrimal acinar cells that produce it. Accordingly, one embodiment of the present invention is directed to the use of lacritin to treat Dry Eye and other disorders requiring the wetting of the eye.

REFERENCES:
patent: 2002/0101604 (2002-08-01), Milne et al.
patent: 2002/0164669 (2002-11-01), Rueben et al.
patent: WO 98/27205 (1998-06-01), None
patent: WO 98/35229 (1998-08-01), None
Rudinger, InPeptide Hormones, J. R. Parsons, ed., University Park Press, Baltimore, pp. 1-7, 1976.
Lumsden, A.J., Dickinson, D.P., and Laurie, G.W., (1998). “Paired oligonucleotide screening for ‘BM 180’ in a human lacrimal gland cDNA library: Clome HL-2”., Am. Society for Cell Biology Annual Meeting.
Sanghi, S., and Laurie, G.W., (1999). “cDNA Cloning and Expression of ‘lacritin’, a novel secreted glycoprotein of the lacrimal gland”., Am. Society for Cell Biology Annual Meeting.
Sanghi, S., Kumar, R. Walton, S., and Laurie, G.W., (2000).“Quantitation of rat lacrimal secretion: novel sandwich ELISA with high sensitivity”., Exp. Eye Res., p. 651-658.
Rudinger, J., ““Characteristics of the amino acids as components of a peptide hormone sequence”,” Peptide Hormones, University Park Press (Baltimore), (June 14, 1976).

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Ocular tear growth factor-like protein does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Ocular tear growth factor-like protein, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Ocular tear growth factor-like protein will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-2778589

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.